| 商品名称 | Dexamethasone Taw |
|---|---|
| 适用类别 | Human |
| 治疗领域 | COVID-19 virus infection;Brain Edema;Respiratory Distress Syndrome, Adult;Asthma;Skin Diseases;Autoimmune Diseases;Arthritis;Vomiting;Inflammation;Eye Diseases;Postoperative Nausea and Vomiting |
| 通用名/非专利名称 | dexamethasone phosphate |
| 活性成分 | Dexamethasone (sodium phosphate) |
| 产品号 | EMEA/H/C/005740 |
| 患者安全信息 | No |
| 许可状态 | Application withdrawn |
| ATC编码 | H02AB02 |
| 是否额外监管 | No |
| 是否仿制药或hybrid药物 | No |
| 是否生物类似药 | No |
| 是否附条件批准 | No |
| 是否特殊情形 | No |
| 是否加速审评 | No |
| 是否罕用药 | No |
| 上市许可开发者/申请人/持有人 | Taw Pharma (Ireland) Ltd |
| 人用药物治疗学分组 | Corticosteroids for systemic use |
| 兽用药物治疗学分组 | |
| 修订号 | |
| 治疗适应症 | Indicated for cerebral oedema, post-traumatic shock-lung syndrome, asthma, skin diseases, autoimmune diseases, rheumatoid arthritis, prophylaxis and treatment of post-operative or cytostatic-induced vomiting, treatment of COVID-19, eye inflammation and infection. |
| 适用物种 | |
| 兽用药物ATC编码 | |
| 首次发布日期 | 2021/01/29 |
| 最后更新日期 | 2021/03/19 |
| 产品说明书 | |
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/human/EPAR/dexamethasone-taw |